Cloudbreak Pharma Inc.

HK$1.19As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2592Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (74.73%)
Mkt cap HK$1.100B
ROIC (229.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.30
9.36%
216.79%
Hold 7|5|2|9|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.02
0.02
20.79%
13.66%
2.53%
(4.67%)
Revenue$M
54.12
56.26
57.92
61.19
8.64%
13.84%
10.69%
12.39%
Peers (US$140.4M)
Cap (US$)
PE
140.4M
6.941x
Capital
TTM
5Y
10Y
Leveragex
0.879
0.132
0.122
EBIT/Intx
0.868
0.344
0.332
Own earn%
(59.78)
27.41
28.98
Sh yield%
39.12
10.59
11.01
Owners
Insiders/Inst%
6.73
42.43
Short interest%
1.88
SBC / revenue%
0.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
23–28
$1 testx
0.0
Incr. ROIC%
23